The resistance to the Bacillus thuringiensis (Bt) toxin Cry2Ab in a greenhouse-originated Trichoplusia ni strain resistant to both Bt toxins Cry1Ac and Cry2Ab was characterized. Biological assays determined that the Cry2Ab resistance in the T. ni strain was a monogenic recessive trait independent of Cry1Ac resistance, and there existed no significant cross-resistance between Cry1Ac and Cry2Ab in T. ni. From the dual-toxin-resistant T. ni strain, a strain resistant to Cry2Ab only was isolated, and the Cry2Ab resistance trait was introgressed into a susceptible laboratory strain to facilitate comparative analysis of the Cry2Ab resistance with the susceptible T. ni strain. Results from biochemical analysis showed no significant difference between the Cry2Ab-resistant and -susceptible T. ni larvae in midgut proteases, including caseinolytic proteolytic activity and zymogram profile and serine protease activities, in midgut aminopeptidase and alkaline phosphatase activity, and in midgut esterases and hemolymph plasma melanization activity. For analysis of genetic linkage of Cry2Ab resistance with potential Cry toxin receptor genes, molecular markers for the midgut cadherin, alkaline phosphatase (ALP), and aminopeptidase N (APN) genes were identified between the original greenhouse-derived dual-toxin-resistant and the susceptible laboratory T. ni strains. Genetic linkage analysis showed that the Cry2Ab resistance in T. ni was not genetically associated with the midgut genes coding for the cadherin, ALP, and 6 APNs (APN1 to APN6) nor associated with the ABC transporter gene ABCC2. Therefore, the Cry2Ab resistance in T. ni is conferred by a novel but unknown genetic mechanism.
T
he Gram-positive soil bacterium Bacillus thuringiensis (Bt) has been widely used as a microbial insecticide in sprayable formulations, and Bt toxins are the primary insecticidal proteins expressed in genetically engineered crops to confer insect resistance (1; ISAAA's GM Approval Database, http://www.isaaa.org /gmapprovaldatabase/). Since the mid-1990s, insect-resistant Bt crops have been rapidly adopted with proven economic and environmental benefits (2, 3) . However, development of insect resistance to Bt toxins threatens the long-term success of application of Bt toxins for insect pest control. The genetic potential of insect populations to evolve Bt resistance has been well shown in laboratory selections, and cases of insect resistance to Bt formulations and Bt crops have occurred in insect populations under selection pressure by Bt sprays and Bt crops in the field (4) (5) (6) (7) (8) .
Studies of insect resistance to Bt toxins have so far been mostly on Lepidoptera pests to the toxin Cry1Ab or Cry1Ac (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) , the two major Bt Cry toxins which are highly toxic to Lepidoptera pests and known to share the same binding sites in target insects (4, 20) . Cry1Ab and Cry1Ac are the primary insecticidal proteins expressed in the current commercial transgenic Bt maize and Bt cotton varieties to target Lepidoptera pests in the field (21) . Resistance to Cry1Ac and Cry1Ab has been observed in both laboratory-selected and field-evolved populations of insect pests (5, 6, 8) .
To delay the development of resistance to Bt toxins in insect populations, the toxin Cry2Ab has been used to pyramid with Cry1Ac in the new generation of Bt crops (1, 6, 21) , as Cry2Ab is known not to share the same binding sites with Cry1Ab or Cry1Ac in insects (22) (23) (24) . The gene pyramiding strategy to combine Cry1Ac and Cry2Ab has proven to be effective in delaying the development of insect resistance to Bt toxins (25, 26) . Nonetheless, resistance to Cry2Ab has been reported in Heliothis virescens, Helicoverpa zea, Helicoverpa armigera, Helicoverpa punctigera, Pectinophora gossypiella, and Trichoplusia ni (8, (27) (28) (29) (30) (31) (32) . These reports have indicated that Cry2Ab-resistant alleles are present in insect populations, and the frequency of resistant alleles will increase with selection. A recent study on the resistance to Cry2Ab in T. ni populations that evolved resistance to the Bt formulation DiPel in greenhouses showed that the DiPel-resistant T. ni populations not only were resistant to Cry1Ac but also had a high frequency of Cry2Ab resistance alleles, allowing their survival on Bt cotton pyramided with Cry1Ac and Cry2Ab (32) .
Current understanding of Bt resistance in insects has established that resistance to Bt toxins can be conferred by different mechanisms in different insects or in different strains of the same insect species (33, 34) . For example, the most common and serious type of Bt resistance, known as "mode 1" type Bt resistance, is a high level of resistance to a Cry1A toxin conferred by reduced binding of the toxin to the receptors in the midgut of target insects and inherited as a recessive trait (35) . Mode 1 resistance has been identified in several Lepidoptera species. However, the resistance can be conferred by different and genetically independent mechanisms which can be associated with the cadherin or ABCC2 gene (12-14, 16, 36) . At present, the understanding of mechanisms of resistance to Bt toxins is primarily on the resistance to Cry1Ab and Cry1Ac. Understanding of the molecular mode of action of Cry2Ab and the mechanism of resistance to Cry2Ab remains very limited (22, 28, 32, 37) . As Cry2Ab is a major Cry toxin in the current Bt crops widely deployed in the field, it is desirable to understand the characteristics of Cry2Ab resistance in insects and the underlying mechanisms that confer resistance to Bt crops.
T. ni is a highly polyphagous insect pest with wide geographic distribution. It is one of the two insect species that have evolved resistance to Bt formulations in agricultural settings (38) . Bt-resistant T. ni populations have been identified in pepper, tomato, and cucumber greenhouses under selection by Bt formulation sprays (38) . These T. ni populations were highly resistant to Cry1Ac and also had a high frequency of Cry2Ab-resistant alleles (32, 39) . More importantly, the dual-toxin-resistant T. ni selected in vegetable production greenhouses can survive on the current generation of Bt cotton plants pyramided with Cry1Ac and Cry2Ab (32) . Therefore, the resistance to Cry2Ab in T. ni is an unique opportunity for studying mechanisms of insect resistance to Bt crops. In this study, the resistance to Cry2Ab in T. ni was biologically and biochemically analyzed, and the genetic association of the Cry2Ab resistance with the genes of putative insect midgut receptors known for Cry toxin binding was determined, in order to understand the genetic mechanism of Cry2Ab resistance in insects.
MATERIALS AND METHODS
Insects and Bt toxins. An inbred strain of T. ni, the Cornell strain, that had been maintained in the laboratory on an artificial diet without exposure to Bt toxins for over 30 years (39) was used as a Bt-susceptible strain. The Bt-resistant T. ni strains used in this study included a T. ni strain resistant to the Bt cotton BollGard II, namely, GLEN-BGII (32) , and a Cry1Ac-resistant strain, GLEN-Cry1Ac-BCS (18) , which was nearly isogenic to the susceptible Cornell strain. Both resistant strains originated from the greenhouse-derived strain GLEN-DiPel (40) . T. ni larvae were reared on a wheat germ-based artificial diet at 27°C with 50% humidity and a photoperiod of 16 h of light and 8 h of darkness.
Cry1Ac protoxin was prepared from the Bt strain HD-73 as previously described by Kain et al. (39) . Cry2Ab toxin solution was obtained from the Monsanto Company (St. Louis, MO) and stored in 50 mM N-cyclohexyl-3-aminopropanesulfonic acid (CAPS) buffer (pH 11) with 2 mM dithiothreitol (DTT) at Ϫ20°C.
Separation of Cry1Ac resistance and Cry2Ab resistance from the GLEN-BGII strain of T. ni. Reciprocal crosses between the GLEN-BGII and the Cornell strains (100 individuals of each) were made to produce an F 1 population. The F 1 population was again crossed with the Cornell strain for two more generations to reduce the frequencies of Cry1Ac-resistant and Cry2Ab-resistant alleles in the experiment population. The resulting progeny were subsequently self-crossed to produce a population (named GLEN-BGIIxCornell) in which the frequency for each resistance allele was expected to be 12.5%. The predicted percentage of homozygotes for both Cry1Ac resistance and Cry2Ab resistance in this GLEN-BGIIxCornell population was 1.56%, and the percentage of individuals resistant to both Cry1Ac and Cry2Ab was only 0.024%, based on Mendel's law of independent assortment, if the Cry1Ac resistance and Cry2Ab resistance were genetically independent of each other. A high dose of Cry1Ac (2 ml of 100 g/ml Cry1Ac spread on the diet surface of ca. 50 cm 2 ) and a high dose of Cry2Ab (2 ml of 440 g/ml Cry2Ab spread on the diet surface of ca. 50 cm 2 ) were used to select the GLEN-BGIIxCornell individuals for Cry1Ac resistance and Cry2Ab resistance, respectively. These high doses were confirmed to kill 100% of homozygous susceptible larvae and heterozygous F 1 larvae from the cross of GLEN-BGII with the Cornell strain in parallel control bioassays. The resulting populations that survived from the selection with Cry1Ac and Cry2Ab, respectively, were named GLEN-BGII-Cry1Ac-SEL and GLEN-GBII-Cry2Ab-SEL, respectively.
Determination of the level of resistance of GLEN-BGII-Cry1Ac-SEL and GLEN-GBII-Cry2Ab-SEL larvae to Cry1Ac and Cry2Ab. Diet overlay bioassays were performed with neonates from the GLEN-BGIICry1Ac-SEL and GLEN-BGII-Cry2Ab-SEL strains as described by Wang
FIG 1
Diagram illustrating preparation of a T. ni backcross family for analysis of genetic association between Cry1Ac resistance and Cry2Ab resistance in the GLEN-BGII strain. Treatment group I was selected with a diagnostic dose of Cry1Ac at 3 g/cm 2 first, and then survivors from Cry1Ac selection were treated with a diagnostic dose of Cry2Ab at 6 g/cm 2 . Treatment group II was selected with a diagnostic dose of Cry2Ab at 6 g/cm 2 first, and survivors from Cry2Ab selection were then treated with a diagnostic dose of Cry1Ac at 3 g/cm 2 . Treatment group III was treated with Cry1Ac (3 g/cm 2 ) and Cry2Ab (6 g/cm 2 ). R 1 and S 1 represent the resistant and susceptible alleles of the Cry1Ac resistance gene, respectively. R 2 and S 2 represent the resistant and susceptible alleles of the Cry2Ab resistance gene, respectively. et al. (18) . The susceptible Cornell strain was used as a susceptible control to determine the levels of resistance to Cry1Ac and Cry2Ab.
Complementation test for allelism of Cry1Ac resistance between the GLEN-GBII and GLEN-Cry1Ac-BCS strains. To determine whether Cry1Ac resistance in the GLEN-BGII strain was conferred by the same gene as in the GLEN-Cry1Ac-BCS strain, which was isolated from the same original greenhouse population GLEN-DiPel (18), the GLEN-BGIICry1Ac-SEL strain was crossed with the GLEN-Cry1Ac-BCS strain to produce F 1 progeny. The F 1 progeny, along with the two parental strains and the Cornell strain, were assayed for their susceptibility to Cry1Ac using the diet overlay assaying method described above.
Analysis of genetic linkage between Cry1Ac and Cry2Ab resistance in T. ni. Determination of genetic linkage between Cry1Ac resistance and Cry2Ab resistance in T. ni was performed as shown in Fig. 1 . Briefly, females from the GLEN-BGII strain were crossed with Cornell strain males, and their F 1 females were crossed with males from the GLEN-BGII strain to generate a backcross population. The neonates from the backcross population were divided into three treatment groups. In the first treatment (group I), neonates were transferred to diet overlaid with toxin Cry1Ac at its discriminating dose (3 g/cm 2 diet surface), and the larvae that reached second instar after 4 days were counted as Cry1Ac-resistant survivors and were subsequently transferred to diet overlaid with Cry2Ab at its discriminating dose (6 g/cm 2 diet surface) to select the Cry2Ab-resistant individuals. In the second treatment (group II), neonates were treated with Cry2Ab at 6 g/cm 2 , and the survivors were then exposed to Cry1Ac at 3 g/cm 2 . In the third treatment (group III), neonates were transferred to diet overlaid with a mixture of Cry1Ac and Cry2Ab at 3 g/cm 2 and 6 g/cm 2 , respectively. Larvae that did not reach second instar after 4 days of feeding on the Cry toxins would eventually die during the larval stage. A total of 150 or 200 larvae were included for each treatment. Survival rates were scored for each treatment.
Data analysis was carried out to test the null hypothesis that Cry1Ac resistance and Cry2Ab resistance were controlled by two independent genes, and there was no genetic linkage between Cry1Ac resistance and Cry2Ab resistance (Fig. 1) . The resistance to Cry1Ac in T. ni is known to be recessive and monogenic (39) . Similarly, the resistance to Cry2Ab in T. ni is also recessive and appears to be monogenic (32) . Therefore, based on the predicted genotypes ( Fig. 1) , it was expected that in treatment group I, 50% of the individuals were resistant to Cry1Ac, and among those Cry1Ac selection survivors, 50% were resistant to Cry2Ab (Fig. 1) . Similarly, for treatment group II, 50% of the individuals were resistant to Cry2Ab, and among the Cry2Ab survivors, 50% of the larvae were resistant to Cry1Ac (Fig. 1) . As for treatment group III, the expected percentage of larvae resistant to both Cry1Ac and Cry2Ab was 25% (Fig. 1) . The 2 test was used to evaluate the statistical significance between the observed and predicted survival rates in each treatment based on the hypothesis that there was no genetic linkage between Cry1Ac and Cry2Ab resistance in the GLEN-BGII strain.
Introgression of the Cry2Ab resistance from the GLEN-BGII strain into the susceptible Cornell strain. The GLEN-BGII strain was crossed with the Cornell strain, and their F 1 progeny were backcrossed with the Cornell strain for two additional generations. The backcross progeny were allowed to intrabreed to generate a backcross population, and the backcross population was selected with Cry2Ab. The Cry2Ab selection was performed with a neonate feeding method on Cry2Ab-overlaid artificial diet (2 ml of 440 g/ml Cry2Ab spread on a diet surface of ca. 50 cm 2 ). The survivors after 7 days on Cry2Ab were transferred to fresh diet without toxin until pupation, and the progeny from the survivors were subsequently used to repeat the introgression process. Two strains were established after backcrossing the original resistant strain with the Cornell strain for 6 and 8 times and were named GLEN-Cry2Ab-BCS6 and GLENCry2Ab-BCS8, respectively.
Generation of a T. ni strain resistant to both Cry1Ac and Cry2Ab nearly isogenic to the laboratory susceptible strain. To generate a T. ni strain resistant to both Cry1Ac and Cry2Ab on the genetic background of the susceptible Cornell strain, the Cry1Ac-resistant strain GLEN-Cry1Ac-BCS (18) and the Cry2Ab-resistant strain GLEN-Cry2Ab-BCS6 were crossed, and their F 1 generation was allowed a self-cross to generate F 2 progeny. The F 2 larvae were selected with both Cry1Ac and Cry2Ab on artificial diet (20 g Cry1Ac and 8.8 g Cry2Ab/cm
2 ) as described above. Survivors from a 4-day selection with Cry1Ac plus Cry2Ab were transferred onto fresh diet until pupation. Two male pupae of the survivors from the selection with Cry1Ac plus Cry2Ab were placed into two separate cages provided with female pupae from the Cornell strain to allow a backcross of the toxin-selected males with susceptible females after their emergence, to further introgress the Cry1Ac resistance and Cry2Ab resistance to the background of the Cornell strain. The F 1 progeny from the two individual backcross families were combined and allowed to self-cross, and the progeny were selected on leaves from BollGard II cotton plants for 7 days as described by Kain et al. (32) . The resulting T. ni strain, named GLEN-Cry1AcϩCry2Ab-BCS, was resistant to both Cry1Ac and Cry2Ab and nearly isogenic to the susceptible Cornell strain. This strain was further selected with a mixture of Cry1Ac (10 g Cry1Ac and 8.8 g Cry2Ab/ cm
2 ) in generations 3, 11, and 14 as described by Wang et al. (18) and selected on BollGard II cotton leaves as described by Kain et al. (32) in generations 5 and 9. Otherwise, this strain was routinely maintained on artificial diet without exposure to Bt toxins.
Midgut digestive protease activity assays. Larval midgut homogenate preparation and protease activity assays were carried out as previously described by Wang et al. (18) . Briefly, actively feeding mid-fifth instar larvae were immobilized on ice for 5 min and dissected on ice to isolate intact midguts containing gut contents. The midguts were then individually weighed and stored at Ϫ20°C. Midgut homogenate (10% [wt/vol]) was prepared by homogenizing a midgut with 9 times the midgut weight of deionized water in a 1.5-ml microcentrifuge tube and used for protease assays.
Total midgut protease activity was determined using azocasein (Sigma, St. Louis, MO) (18) . A 20-l aliquot of midgut homogenate was mixed with 150 l 1% azocasein in 50 mM NaHCO 3 -Na 2 CO 3 buffer (pH 10) and incubated at 28°C for 2 h. The reaction was stopped by addition of 170 l of 10% trichloroacetic acid. The mixture was incubated at room temperature for 1 h and then centrifuged at 16,000 ϫ g for 10 min. One hundred microliters of the supernatant containing digested azocasein products was mixed with an equal volume of 1 M NaOH, and its optical absorbance at 450 nm was determined in a microplate reader (Dynex Technologies, Chantilly, VA).
Midgut serine protease activities, including elastase, trypsin, and chymotrypsin activities, were assayed by following the enzyme assay procedures described by Wang et al. (18) , except that all protease assays were conducted at pH 10 using chromogenic substrates specific to the 3 types of serine proteases (N-succinyl-L-alanyl-L-alanyl-L-alanine-p-nitroanilide for elastase, Na-benzoyl-L-arginine p-nitroanilide for trypsin, and N-succinyl-Ala-Ala-Pro-phenylalanine p-nitroanilide for chymotrypsin activity). The digestion of the substrate in the protease assay was recorded by spectrophotometrically monitoring the release of p-nitroaniline from the peptidolytic reaction at 405 nm at 28°C, and the enzymatic activity from each sample was calculated using the data points in the linear portion of the initial reaction curves as described by Wang et al. (18) .
Midgut aminopeptidase activity was determined as described by Wang et al. (41) . Twenty microliters of midgut homogenate was mixed in 2 ml of 0.1 M Tris-HCl (pH 8.6) containing 1 mM leucine p-nitroanilide (Sigma), immediately followed by monitoring of the increase of optical absorbance at 405 nm at 26°C for 5 min. The aminopeptidase activity from each sample was calculated using the data points in the linear portion of the initial reaction curves (41) .
Zymogram analysis of midgut proteases. The midgut proteases were profiled by zymogram analysis using the method described by Wang et al. (18) . Briefly, 1 l of 10% midgut homogenate was solubilized in SDS-PAGE sample buffer without addition of a reducing agent and boiling, and the proteins were separated by SDS-PAGE with a 10% separation gel.
After electrophoresis, the gel was washed with 2% Triton X-100 for 15 min, followed by incubation in 2% casein (Sigma) prepared in 50 mM Tris-HCl (pH 8) for 3 h at room temperature. The midgut protease activities were visualized by Coomassie blue staining of the gel after a brief rinse of the gel in deionized water.
Proteolytic digestion of Cry2Ab toxin with T. ni larval midgut digestive fluid. To compare the proteolytic activities of the larval midgut fluid from the susceptible and Cry2Ab-resistant T. ni on Cry2Ab, in vitro digestion of Cry2Ab toxin by larval midgut digestive fluid was performed, using the method reported by Wang et al. (18) . Briefly, larval midgut fluid was collected as regurgitant from mid-fifth instar larvae by stimulation of the larval mouth parts. Ten microliters of 44 g/ml Cry2Ab was incubated with 10 l of midgut fluid prepared in a 10-fold serial dilution at 26°C for 60 min as described by Wang et al. (18) . The proteolytic degradation of Cry2Ab was terminated by heating samples in SDS-PAGE sample buffer at 100°C for 5 min, and the degradation of Cry2Ab was examined by SDS-PAGE analysis, followed by Coomassie blue staining.
Analysis of midgut ALP. For midgut alkaline phosphatase (ALP) activity assays, 10 l of midgut homogenate was mixed with 2 ml of ALP assay buffer (100 mM Tris-HCl [pH 9.5], 100 mM NaCl, 5 mM MgCl 2 ) containing 1.2 mM p-nitrophenyl phosphate disodium (Sigma). ALP activity was measured as changes of optical absorbance at 405 nm at 26°C for 10 min.
Midgut ALP in the midgut tissue was also examined after separation by SDS-PAGE as described by Jurat-Fuentes and Adang (42) and by Western blotting using antibodies specific to T. ni ALP. Ten microliters of midgut tissue homogenate (10%) was solubilized in SDS-PAGE sample buffer without boiling. The solubilized midgut proteins were separated on a 10% SDS-PAGE gel and transferred to Immobilon-P membrane (Millipore, Billerica, MA) by electrotransfer. The membrane was then washed with the ALP buffer for 15 min at room temperature, followed by incubation in 330 g/ml of nitro blue tetrazolium (NBT) and 165 g/ml of 5-bromo-4-chloro-3-indolyl phosphate (BCIP) in ALP buffer to visualize the ALP activity.
For Western blot analysis of the midgut ALP, proteins from the midgut homogenate were solubilized by boiling in SDS-PAGE sample buffer, separated by 10% SDS-PAGE, and then transferred onto Immobilon-P membrane. The membrane was incubated with 3% bovine serum albumin (BSA) in phosphate-buffered saline (PBS) to block nonspecific binding sites and then incubated at 4°C overnight with an antiserum specific to the protein sequence DEESQAGRRTDGRNLIEE of the T. ni membrane-bound ALP (GenBank accession no. AEG79734), followed by an incubation with goat anti-rabbit IgG antibody conjugated with alkaline phosphatase (The Jackson Laboratory, Bar Harbor, ME) after several washes of the membrane with PBS. Colorimetric detection of ALP activity was achieved by incubating the membrane with the NBT-BCIP substrate as described above.
Midgut esterase analysis. Larval midgut esterase activities from the GLEN-Cry2Ab-BCS8 and Cornell strains were compared by midgut esterase activity assays and isozyme analysis (18) . Larval midgut was isolated from mid-fifth instar larvae without loss of its contents as described above and homogenized in 0.1% Triton X-100 to make 10% (wt/vol) midgut lysate. The midgut lysate was clarified by centrifugation at 16,000 ϫ g for 10 min, and the supernatant was used for esterase activity and isozyme profile analyses. For esterase activity assays, 5 l of midgut lysate was mixed in 3 ml of 0.1 M sodium phosphate buffer (pH 6.5) containing 2.5 mg/ml of Fast Blue RR and 0.1 mg/ml of ␣-naphthyl acetate (Sigma) and incubated at 26°C. Changes of optical absorbance at 450 nm in 5 min were recorded to determine the enzymatic activity. For midgut esterase isozyme analysis, 10% native PAGE was performed to separate the proteins from 10 l of midgut lysate. The gel was washed twice with 0.1 M sodium phosphate buffer (pH 6.5) for 10 min and then incubated at room temperature in 0.1 M sodium phosphate buffer (pH 6.5) containing 0.75 mg/ml of Fast Blue RR and 0.2 mg/ml of ␣-naphthyl acetate to colorimetrically detect the esterase activity in the gel. The colorimetric reaction was stopped by fixation of the gel in 5% acetic acid and 10% methanol when the activities of esterase isozymes were visualized as bands on the gel.
Hemolymph melanization assays. Hemolymph plasma melanization assays were employed to compare the immune status of the susceptible and resistant larvae (43) , following the procedure described by Wang et al. (18) . Twenty-five microliters of hemolymph was collected from a cut proleg of a mid-fifth instar larva and immediately mixed in 125 l PBS on ice, followed by centrifugation at 16,000 ϫ g for 4 min to remove the hemocytes. One hundred microliters of the plasma preparation was mixed with 100 l PBS and transferred to a 96-well microplate, and the optical density at 490 nm was recorded for a period of 180 min with a microplate reader as described above.
Genotyping of candidate Cry toxin receptor genes in T. ni strains. To identify DNA markers to differentiate the candidate Cry toxin receptor gene alleles between the susceptible Cornell strain and the greenhouseoriginated resistant strain GLEN-BGII, primers specific to the cadherin, aminopeptidase N 1 (APN1) to APN6, and ALP genes were designed based on their known cDNA sequences (Table 1 ) and used for PCR amplification of the genomic DNA fragments of corresponding genes from the Cornell strain and GLEN-BGII strain individuals. PCR-amplified genomic DNA fragments were sequenced to identify the sequence variations different between the two strains, and these unique sequences were used as markers for genetic linkage analysis of Cry2Ab resistance with the candidate Cry toxin receptor genes.
For genotyping of the candidate Cry toxin receptor genes, genomic DNA was prepared from fifth instar larvae or adults using a rapid DNA isolation method (44) , and PCRs were performed to amplify the genomic DNA fragments of the cadherin, APN1 to APN6, and ALP genes, using the genomic DNA lysates as the templates with the specific primers. PCR products were cleaned by treatment of 5 l PCR product with 0.5 U of shrimp alkaline phosphatase and 1.25 U of exonuclease I (USB Biochemicals, Cleveland, OH) at 37°C for 60 min, followed by an incubation at 90°C for 10 min to inactivate the enzymes (45) . Sequencing reactions were carried out using the BigDye Terminator v3.1 cycle sequencing kit (Applied Biosystems, Foster City, CA), following the instructions provided by 
the manufacturer, and the products were purified by Sephadex G-50 columns in a 96-well filter plate (Corning, Tewksbury, MA). The purified DNA sequencing reaction products were subjected to analysis (sequence reading) at the Biotechnology Resource Center of Cornell University (Ithaca, NY). Sequence data were analyzed using the Lasergene software package (DNAStar, Madison, WI). Genetic linkage analysis of candidate Cry toxin receptor genes with Cry2Ab resistance in T. ni. A susceptible male from the Cornell strain was crossed with a Cry2Ab-resistant female from the GLEN-BGII strain to generate F 1 progeny, and then an F 1 female was crossed with a resistant male from GLEN-BGII to generate a backcross family. Neonates from the backcross family were reared on diet without toxin (as nonselection controls) or on diet overlaid with a discriminating dose of Cry2Ab (2 ml of 440 g/ml toxin spread on the diet surface of ca. 50 cm 2 ) for 7 days to eliminate susceptible heterozygous individuals. Sixteen individuals were randomly selected from Cry2Ab-selected larvae and 16 larvae from the nonselection controls for genotyping of the receptor gene alleles as described above, to examine the genetic association of the toxin receptor genes with the Cry2Ab resistance.
RESULTS
The Cry1Ac and Cry2Ab resistance traits in the T. ni GLEN-BGII strain segregated independently. The GLEN-BGIIxCornell population was generated by 3 sequential crosses of GLEN-BGII with the Cornell strain, followed by a self-crossing, and then was selected with Cry1Ac and Cry2Ab, respectively. The two resulting populations, GLEN-BGII-Cry1Ac-SEL and GLEN-BGII-Cry2Ab-SEL, showed high-level resistance to the toxin used for the selections. The GLEN-BGII-Cry1Ac-SEL strain showed 1,167-fold resistance to Cry1Ac but had only 4-fold resistance to Cry2Ab ( Table 2 ). The GLEN-BGII-Cry2Ab-SEL strain selected with Cry2Ab had a high level of resistance to Cry2Ab (Ͼ518-fold) but only exhibited a low level of resistance to Cry1Ac (7.6-fold). Clearly, the Cry1Ac resistance and Cry2Ab resistance in the GLEN-BGII strain segregated independently and were separated into two different populations by selection with Cry1Ac and Cry2Ab, respectively.
In addition, treatment of the larvae of the backcross family ( Fig. 1) with a discriminatory dose of Cry1Ac or Cry2Ab to select homozygous resistant individuals resulted in survival rates of 49% and 46%, respectively, consistent with the predicted survival rate of 50% for monogenic recessive resistance (Table 3) . A subsequent treatment of the survivors from the Cry1Ac selection with Cry2Ab resulted in a survival rate of 56%, and treatment of the survivors from the Cry2Ab selection with Cry1Ac resulted in a survival rate of 48%, both of which were consistent with the predicted 50% survival rate based on the assumption that Cry1Ac resistance and Cry2Ab resistance in T. ni are independent (Table 3) . Moreover, in the selection of the backcross family individuals with a mixture of Cry1Ac and Cry2Ab, the survival rate was 23% which was also consistent with the predicted survival rate of 25% based on the assumption that Cry1Ac resistance and Cry2Ab resistance are independent (Table 3) .
Cry1Ac resistance in the GLEN-BGII strain shared the same genetic basis with that of the Cry1Ac resistance in the GLENCry1Ac-BCS strain. Results from the genetic complementation test showed that the F 1 progeny from the cross between GLEN-BGII-Cry1Ac-SEL and GLEN-BGII-Cry1Ac-BCS were highly resistant to Cry1Ac, similar to the resistant parental strains (Table  4 ). This result showed that the Cry1Ac resistance-conferring mutations in the two resistant strains share the same genetic locus.
Introgression of the Cry2Ab resistance trait from the GLEN-BGII strain to the susceptible Cornell strain background. By crossing and backcrossing of the GLEN-BGII strain with the susceptible Cornell strain and selection with Cry2Ab, two backcross strains, GLEN-Cry2Ab-BCS6 and GLEN-Cry2Ab-BCS8, were established. Neonate bioassays determined that the LC 50 of Cry2Ab for both of the strains was Ͼ440 g/ml, while the 50% lethal concentration (LC 50 ) of Cry2Ab for the susceptible Cornell strain was 0.3 g/ml (32). Bioassays of fifth instar larvae with 440 g/ml Cry2Ab determined that the larvae from GLEN-Cry2Ab-BCS8 were highly resistant to Cry2Ab, showing 0% mortality (n ϭ 10) and completion of pupation. However, the fifth instar larvae from the Cornell strain showed a lower growth rate and eventually 100% mortality (n ϭ 10) in 10 days.
Combining of Cry1Ac and Cry2Ab resistance in T. ni conferred resistance to BollGard II plants. The Cry1Ac resistance and Cry2Ab resistance in two T. ni strains, GLEN-Cry1Ac-BCS and GLEN-Cry2Ab-BCS6, both of which were nearly isogenic to the Cornell strain, were combined into one strain by a cross between the two strains and selection of the F 2 progeny with both Cry1Ac and Cry2Ab, followed by an additional backcross with the Cornell strain and selections. The resulting strain of T. ni, GLENCry1AcϩCry2Ab-BCS, was highly resistant to Cry1Ac and Cry2Ab and nearly isogenic to the susceptible Cornell strain. The combining of Cry1Ac resistance and Cry2Ab resistance reconstituted the resistance to the dual-toxin BollGard II cotton plant leaves (Table 5) , exhibiting the adjusted survival at a level of 0.52 Ϯ 0.08 (survival rate on Bt cotton leaves/survival rate on non-Bt cotton leaves), similar to the original GLEN-BGII strain (32) .
No difference in midgut protease activities was observed between Cry2Ab-resistant and -susceptible T. ni larvae. The total caseinolytic protease activity in the larval midgut homogenates prepared from the GLEN-Cry2Ab-BCS8 strain and that from the Cornell strain were not statistically different (Fig. 2) . The 3 specific types of serine proteinase activities, the trypsin, chymotrypsin, and elastase activities, in the larval midgut of the two strains were also similar, without statistical difference between the resistant and susceptible strains (Fig. 2) . Moreover, aminopeptidase activity assays of midgut homogenates determined that the midgut aminopeptidase activity (leucyl aminopeptidase activity) in the resistant larvae was not different from that in the susceptible strain (Fig. 2) . The aminopeptidase activity in a midgut homogenate is known to be associated with the midgut epithelium (Ͼ98%), with a negligible amount (Ͻ2%) in the midgut lumen in T. ni larvae (41) .
Zymographic analysis of midgut caseinolytic activities showed that the midgut protease composition was complex, as previously reported by Wang et al. (18) . However, there was no observed significant difference in the protease activity profiles between the GLEN-Cry2Ab-BCS8 strain and the susceptible Cornell strain (Fig. 3) .
Incubation of Cry2Ab toxin with T. ni larval midgut digestive fluid showed that midgut digestive proteases were highly active to the toxin. A 1-h incubation of Cry2Ab at 22 g/ml with 10% midgut fluid resulted in complete degradation of the toxin (Fig.  4) . Treatment with 1% midgut fluid caused degradation of most of the toxin. However, there was no significant difference observed between the Cry2Ab-resistant and -susceptible strains in the extent of Cry2Ab degradation and pattern of the degradation products.
No difference in midgut ALP activities was observed between Cry2Ab-resistant and -susceptible T. ni. ALP activity assays of midgut homogenates showed that there was no significant difference between the larvae from the GLEN-Cry2Ab-BCS8 and Cornell strains in midgut-associated ALP activity (Fig. 5A) . Analysis of midgut ALP activity separated by native SDS-PAGE and transferred onto an Immobilon blot showed that the major T. ni ALP activity migrated on the SDS-PAGE gel with an apparent molecular mass of 100 kDa (Fig. 5B) . The ALP activity (staining intensity) varied among the individual larvae within both the susceptible and the resistant strains, but there was no significant difference between the resistant and the susceptible larvae in molecular mass and activity of the ALP (Fig. 5B) . Western blot analysis of the ALP determined that T. ni ALP was a 65-kDa protein by SDS-PAGE, similar to the predicted molecular mass based on the protein sequence (GenBank accession no. AEG79734) (Fig. 5C) . Consistent with the results from the ALP activity assays in solution and on the blot (Fig. 5A and B) , the result from Western blot analysis showed that the ALP quantity (Fig. 5C ) varied noticeably among different individuals, but there was no observed significant difference between the resistant and the susceptible larvae in molecular mass, activity, and quantity.
No difference in midgut esterase activities nor melanization activities of hemolymph plasma was observed between Cry2Ab-resistant and -susceptible T. ni larvae. Significantly increased midgut esterase activity and elevated immune response have been reported to be associated with Bt resistance in some Lepidoptera pests (43, 46, 47) . Determination of esterase activity in midgut lysate from T. ni larvae from the Cornell strain and the GLENCry2Ab-BCS8 strain showed that there was no difference in midgut esterase activities between the resistant and susceptible larvae (Fig. 6A) . Esterase isozyme analysis further confirmed that there was no difference in midgut esterase activities and isozyme compositions between the two strains, although apparent variations in activities and isozyme patterns were observed among individual larvae of the same strains (Fig. 6B) .
Comparative analysis of larval hemolymph plasma melaniza- tion activities indicated that there was no difference between the two strains in melanization activities. The relative melanization activity of the hemolymph plasma was determined to be 100% Ϯ 24% (mean Ϯ 95% confidence interval [CI]; n ϭ 3) for the susceptible strain and was 120% Ϯ 36% (mean Ϯ standard error [SE]; n ϭ 3) for the resistant strain, calculated from the melanization reaction in the first 20 min. Identification of allelic markers for the candidate toxin receptor gene. By PCR amplification and sequencing of genomic DNA fragments of the cadherin, ALP, and APN1 to APN6 genes from the Cornell and the GLEN-BGII strains, allelic marker sequences were identified in these 8 genes between the 2 strains (see Fig. S1 to S8 in the supplemental material). For the cadherin gene, the 495-bp PCR fragment, covering the cDNA sequence from nucleotide positions 4911 to 5114 (GenBank accession no. JF303656) with an intron of 291 bp, harbored 12 single nucleotide polymorphisms (SNPs) between the fragments of the allele from the susceptible Cornell strain, named cad C (GenBank accession no. JN849389), and the allele from the resistant GLEN-BGII strain, named cad G (GenBank accession no. JN849388) (see Fig. S1 ). These cad fragment sequences are the same as those identified earlier from the T. ni Cornell strain and the GLEN-Cry1Ac-BCS strain (48) . For the ALP gene, the PCR fragment covering the cDNA sequence (accession no. JF825967) from nucleotide positions 457 to 618 had an intron of 343 bp (see Fig. S2 ). Three SNPs and an 11-nucleotide deletion were identified between the fragments of the two ALP alleles, alp C (GenBank accession no. KP717042) and alp G (GenBank accession no. KP717041), from the Cornell and GLEN-BGII strains, respectively. For the 6 APN (APN1 to APN6) genes, the alleles from the Cornell strain were named apn1 C , apn2 C , apn3 C , apn4 C , apn5 C , and apn6 C (GenBank accession no. KP717044, KP717046, KP717048, KP717050, KP717052, and KP717054), and the alleles from the GLEN-BGII strain were named apn1 G , apn2 G , apn3 G , apn4 G , apn5 G , and apn6 G (GenBank accession no. KP717043, KP717045, KP717047, KP717049, KP717051, and KP717053). In the PCR fragments of the APN genes, 5 SNPs and 1 indel were found in apn1, 12 SNPs and 8 indels were found in apn2, 8 SNPs were found in apn3, 2 SNPs were found in apn4, 20 SNPs and 3 indels were found in apn5, and 4 SNPs were found in apn6 (see Fig. S3 to S8). Cry2Ab resistance in T. ni was not genetically linked with the candidate Cry toxin receptor genes. Genotyping of 16 individuals from the nonselected controls of the backcross family for linkage analysis, using the allelic markers for the cadherin, APN1 to APN6, and ALP genes, determined that 7 individuals were cad G cad C , 7 individuals were alp G alp C , and 10 individuals were apn G apn C for the 6 APN genes (Table 6 ). This result was consistent with the random assortment of the genes with the predicted homozygous and heterozygous alleles at the ratio of 1:1 (P values were 0.62 for the cad and alp genotypes and 0.32 for the apn genotypes by 2 test). Genotyping of the survivors of the Cry2Ab-treated backcross family individuals showed that among the 16 survivors analyzed, 6 individuals were cad G cad C , 9 were alp G alp C , and 12 individuals were apn G apn C for the 6 APN genes, similar to the nonselected group (Table 6 ), showing that these candidate genes did not cosegregate with the resistance gene. In other words, the genes for these candidate Cry receptors segregated independently of the Cry2Ab resistance-conferring gene in T. ni.
DISCUSSION
Bt Cry toxins are a large family of insecticidal proteins, currently including over 750 sequence submissions that have been divided into 73 groups (49) . The Cry toxins from the different groups differ from each other in host specificity and toxicity. Although the intoxication pathways and molecular interactions of Cry toxins with insect midgut proteins are not fully understood, it has been well documented that the specific binding of different toxins to the midgut brush border membrane proteins varies, depending on the toxins and host insects (4, 33, 50) . Cry1A and Cry2A toxins are known to bind to different binding sites in the insect midgut, and consequently, Cry1A resistance caused by binding site alteration (also known as "reduced toxin binding") usually does not exhibit cross-resistance to Cry2A toxins (22, 23, 51) . In T. ni, it has been determined that binding site alteration-mediated Cry1Ac resistance does not confer resistance to Cry2Ab (18, 32) . Results from this study confirmed that Cry1Ac resistance in T. ni does not confer cross-resistance to Cry2Ab and vice versa ( Table 2) . The results from this study determined that Cry1Ac resistance and Cry2Ab resistance in T. ni are conferred by two genetically independent mechanisms. The genes that control the resistance to Cry1Ac and the resistance to Cry2Ab showed independent segregation, and consequently selection of the backcross family (GLEN-BGIIxCornell) individuals with Cry1Ac and Cry2Ab, respectively, resulted in two strains resistant to Cry1Ac and Cry2Ab, respectively, with very minimal cross-resistance (Table 2) . Bioassays of the backcross population in 3 different treatment groups (Fig. 1) further confirmed that the Cry1Ac resistance and Cry2Ab resistance in T. ni are independent, conferred by two genetically independent mechanisms (Table 3 ). The genes controlling the Cry1Ac resistance and Cry2Ab resistance are in different linkage groups or on different chromosomes, in other words. These findings support the biotechnological strategy to pyramid Cry1Ac and Cry2Ab for management of insect resistance to Bt crops.
Cry1Ac resistance and Cry2Ab resistance have been selected in laboratory strains of P. gossypiella (29) . Interestingly, the Cry1Ac resistance and Cry2Ab resistance selected with Cry1Ac and Cry2Ab, respectively, showed asymmetrical cross-resistance patterns in P. gossypiella (29) . The Cry1Ac-resistant P. gossypiella strain selected with Cry1Ac showed very minimal cross-resistance to Cry2Ab, but the Cry2Ab-resistant P. gossypiella selected with Cry2Ab (resistance ratio, 240-fold) showed cross-resistance to Cry1Ac (resistance ratio, 420-fold). In this study, the BollGard II-resistant strain of T. ni (GLEN-BGII) was crossed with the susceptible Cornell strain for 3 generations to generate an experimental population, GLEN-BGIIxCornell, in which the predicted frequencies of the Cry1Ac resistance gene allele and the Cry2Ab resistance gene allele were both 12.5%, or the frequency of homozygous resistant genotype for Cry1Ac and that for Cry2Ab were both 1.56%. Selection of this T. ni population with a high dose of Cry1Ac and a high dose of Cry2Ab, respectively, effectively selected a Cry1Ac-resistant strain and a Cry2Ab-resistant strain ( Table 2 ). No significant cross-resistance was observed between the resistance to Cry1Ac and that to Cry2Ab, in contrast to the asymmetrical cross-resistance patterns between the two toxin selections observed in P. gossypiella.
Multi-Cry toxin crops were commercialized in 2002, and their adoption was rapidly increased a few years later in the United States (8) . However, Bt sprays containing a mixture of both Cry1A and Cry2A toxins have been used in agriculture for decades, and field resistance to Bt sprays has happened (38, 52, 53) . These field populations that developed resistance under selection with Cry1A and Cry2A toxins in the sprays could confer resistance to Bt crops pyramided with Cry1Ac and Cry2Ab (32) , and thus provided a biological system for studying resistance mechanisms that can be selected in populations under the selection pressure from multi- toxin Bt crops. The resistance of T. ni to the dual-toxin Bt cotton BollGard II is conferred by two genetically independent resistance mechanisms. Both mechanisms confer a high-level resistance to the corresponding toxin, Cry1Ac or Cry2Ab. However, these two resistance traits are genetically independent of each other (18) ( Table 2 ). Experimental combination of these two resistant traits could reconstitute the dual resistance to the two toxins and consequently to BollGard II plants ( Table 5 ). The genetic complementation test in this study determined that the BollGard II-resistant strain GLEN-BGII shares the same genetic basis with the GLEN-Cry1Ac-BCS strain for Cry1Ac resistance (Table 4 ). This finding is not surprising as both strains were derived from the same original DiPel-resistant greenhouse population (18, 39) .
Cry2Ab resistance in insects is poorly understood at present. Similarly to the "mode 1" type of resistance to Cry1Ac, high-level resistance specific to Cry2Ab may be conferred by reduced binding of the toxin to the midgut brush border membranes in target insects, as found in H. armigera and H. punctigera (22) . However, the biochemical or genetic mechanisms of Cry2Ab resistance in insects have yet to be identified.
The insect midgut is highly rich in proteases, and protease alteration has been observed in insects resistant to Cry1A toxins (54, 55) . The series of analyses of larval midgut proteases from the susceptible strain and its near-isogenic Cry2Ab-resistant T. ni strains in this study (Fig. 2 to 4) did not show detectable alteration of larval midgut proteases in the resistant strain in caseinolytic, elastase, trysin, and chymotrypsin activities, protease zymographic profiles, and in proteolytic activity to Cry2Ab toxin. Therefore, the results from this study indicate that the resistance to Cry2Ab in T. ni is not likely due to alteration of midgut protease activities. Alterations of midgut esterase expression (47) and heightened immune response have been reported to confer Bt resistance, which is often at a low resistance level (43) . The results from this study showed no detectable changes of hemolymph plasma melanization activity nor midgut esterase activity and composition (Fig. 6) . Therefore, these enzymatic activities did not change in the Cry2Ab-resistant GLEN-Cry2Ab-BCS T. ni strain (Fig. 2 to 6 ) nor in the Cry1Ac-resistant GLEN-Cry1Ac-BCS T. ni strain (18) , both of which were derived from the same GLENDiPel strain resistant to the Bt formulation DiPel (39) .
So far, insect midgut proteins that may serve as Cry toxin receptors have been studied mainly for Cry1A toxins (33, 50, 56) . Whether a Cry toxin binds to the midgut brush border membrane vesicle (BBMV) determined in vitro does not always correlate with resistance. A resistant strain of P. gossypiella selected with Cry1Ac exhibited typical "mode 1" resistance to both Cry1Ab and Cry1Ac, but the binding of Cry1Ac to the midgut BBMV from the resistant P. gossypiella was not changed, although the binding of Cry1Ab was significantly reduced (57) . Similarly, a Cry1Ac-selected H. virescens strain, YHD2, was highly resistant to Cry1Aa, Cry1Ab, and Cry1Ac, but there was no change in the binding of Cry1Ab and Cry1Ac to the midgut BBMV and BBMV proteins from the YHD2 strain (58) . What midgut proteins that Cry2A toxins bind to remain unknown at present. However, it is known that different types of Cry toxins may interact with some of the same or similar midgut proteins in the intoxication pathway, even though the different Cry toxins may bind to different sites in the insect midgut. For example, APNs are known to be receptors for Cry1Ab and Cry1Ac (59) (60) (61) , and Cry1C is known not to share the same binding sites with Cry1Ac in the midgut (4). However, the lack of an APN in S. exigua leads to resistance to Cry1C (62) , which indicates that the APN also plays an important role in the intoxication pathway of Cry1C. Moreover, the midgut cadherin is a known midgut receptor for Cry1A toxins, and mutations of the midgut cadherin gene have been identified to be associated with high-level resistance to Cry1Ac in H. virescens, P. gossypiella, and H. armigera (9, 12, 14, 63) . Similarly, Cry3, Cry4, and Cry11 toxins also bind to the midgut cadherin in their target insects (64) (65) (66) (67) , and it has been well documented that a fragment of the midgut cadherin from target insects could synergize the toxicity of Cry toxins from different groups, including in Cry1A, Cry1C, Cry3A, Cry3B, Cry4B, and Cry8C, in insects from Lepidoptera, Coleoptera, and Diptera (67) (68) (69) (70) (71) (72) . Therefore, it is worthwhile to examine the genetic association of Cry2Ab resistance with the genes known to be receptors for Cry1Ac in T. ni, although the midgut proteins that Cry2Ab binds to are currently unknown. The results from the genetic linkage analysis in this study (Table 6 ) determined that the Cry2Ab resistance in T. ni is not genetically associated with the genes coding for the midgut cadherin, 6 APNs, and the membrane-bound ALP. Furthermore, as the Cry2Ab resistance in T. ni is not genetically associated with Cry1Ac resistance, which is genetically linked to the ABCC2 gene locus (16), Cry2Ab resistance in T. ni is not genetically linked with the ABCC2 gene either. In other words, the gene that controls the resistance to Cry2Ab in T. ni is on a chromosome different from those that harbor the genes coding for the cadherin, APNs, ALP, and ABCC2. Therefore, the resistance to Cry2Ab in T. ni is conferred by a novel genetic mechanism, and the resistance gene needs to be identified. 
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